"10.1371_journal.pone.0086570","plos one","2014-01-23T00:00:00Z","Keith Moore; Gautam Ghatnekar; Robert G Gourdie; Jay D Potts","University of South Carolina School of Medicine, Columbia, South Carolina, United States of America; FirstString Research Inc., Mount Pleasant, South Carolina, United States of America; Medical University of South Carolina, Charleston, South Carolina, United States of America; Virginia Polytechnic and State University Carilion, Roanoke, Virginia, United States of America","Conceived and designed the experiments: KM GG RGG JDP. Performed the experiments: KM. Analyzed the data: KM JDP. Contributed reagents/materials/analysis tools: GG RGG JDP. Wrote the paper: KM JDP. Funding: GG.","Funding for this project was partially provided by FirstString Research Inc. as a means of investigating translational research models for the (αCT1) peptide and to determine the peptide's method of action. FirstString Research holds the patent for (αCT1) exclusively (patent # 8357668). Keith Moore and Jay D. Potts have no financial or non-financial competing interests to disclose. Robert G. Gourdie is a former post doctoral mentor to Gautam Ghatnekar, the president and CEO of FirstString Research. Robert G. Gourdie does not currently have any financial or non-financial competing interests stemming from this project. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2014","01","Keith Moore","KM",4,TRUE,4,1,2,2,TRUE,TRUE,FALSE,0,NA,FALSE
